Fat loss
Retatrutide
- 5mg*10vials USD 45.00
- 10mg*10vials USD 85.00
Reference price. The concierge confirms the amount before payment.
4.2 / 5 · 3675 reviewsAfter the order is submitted, quote the order number when you write to the concierge.
Features
Triple receptor agonist, offering the most potent fat-loss effect (24% weight reduction in clinical settings)
Overview
Retatrutide is an investigational triple-receptor agonist peptide (targeting GLP-1, GIP, and glucagon receptors) currently under development for the treatment of obesity and type 2 diabetes. Phase II clinical trials have demonstrated significant weight loss, with patients in the high-dose group achieving a weight reduction of up to 24% over 48 weeks. This educational program outlines a once-weekly subcutaneous administration regimen, incorporating a gradual dose-escalation approach to minimize gastrointestinal side effects.
Precautions
Reconstitution: Add 1.0 mL of bacteriostatic water → ~ 5.0 mg/mL concentration
Typical weekly dosage range: 2–8 mg once weekly (gradually increased over 8–12 weeks)
Easy measurement: At 5.0 mg/mL, 1 unit = 0.01 mL ≈ 50 mcg (using a U-100 insulin syringe)
How to use
1. Draw 1.0 mL of bacteriostatic water using a sterile syringe.
2. Inject slowly along the inner wall of the vial; avoid creating foam.
3. Gently swirl or roll the vial until the contents are dissolved (do not shake).
4. Label with the date and store refrigerated at 2–8°C, protected from light.
5. Use within 4 weeks of reconstitution.
Storage
Lyophilized: Store at -20°C or lower; stable for up to 24 months.
After reconstitution: Store at 2–8°C; use within 4 weeks.
Allow the vial to reach room temperature before opening to minimize condensation.
Reviews
4.2 / 5
3675 reviews
Showing the latest 100 reviews.
-
★★★★★
VXE•••••••49A0
United Kingdom
2026-10-26 18:42
The order arrived complete. The packing list was right. I would order again.
-
★★★★★
VX5•••••••FAF1
Germany
2026-10-26 14:49
The outer box was slightly scuffed. The label matched the listing. The order was right.
-
★★★★★
VXF•••••••1BEB
France
2026-10-26 10:56
The first delivery estimate was a bit optimistic. The vial was undamaged. I would still order again.
-
★★★★★
VX9•••••••64F1
Canada
2026-10-26 07:04
The reply was short, then the shipment moved. The storage note was clear. Packing did its job.
-
★★★★★
VXD•••••••E9A8
United States
2026-10-26 03:11
The shipment was handled carefully. The inner seal was intact. Everything checked out.
-
★★★★★
VX0•••••••3E25
Singapore
2026-10-25 23:18
Tracking was a day late. What I ordered was in the box. A fair outcome once it arrived.
-
★★★★★
VXC•••••••6F63
Canada
2026-10-25 19:25
The outer carton was solid. The closure was clean. Pleased with how it was sent.
-
★★★★★
VXC•••••••11EB
United States
2026-10-25 15:33
The handoff at the depot was slow. The product matched the page. A fair delivery overall.
-
★★★★★
VXA•••••••508B
Hong Kong
2026-10-25 11:40
The parcel sat at the depot for a day. The label was clear. Not fast, but the order was right.
-
★★★★★
VX1•••••••D0F8
United Kingdom
2026-10-25 07:47
The first delivery estimate was a bit optimistic. The contents were as stated. A fair delivery overall.
Buyer review
Enter the order number and the phone number from checkout. Both must match an order that includes this product.
Also listed
Fat loss
Cagrilintide
Cagrilintide is a long-acting, acylated amylin analogue—a pancreatic hormone—designed for once-weekly subcutaneous injection. It activates central amylin receptors, promoting satiety, slowing gastric emptying, and reducing food intake. In Phase 2 and Phase 3 clinical trials, cagrilintide induced dose-dependent weight loss, with side effects primarily being gastrointestinal in nature.
Reference priceUSD 113.00
Fat loss
CJC-1295+IPA(CP10)
This formulation combines CJC-1295 (without DAC)—a modified growth hormone-releasing hormone (GHRH) analog—with Ipamorelin, a selective growth hormone secretagogue (GHS). CJC-1295 (without DAC) produces a sustained, dose-dependent increase in GH and IGF-1 levels, while Ipamorelin selectively stimulates GH release without increasing ACTH or cortisol.
Reference priceUSD 116.00
Fat loss
Tirzepatide
Tirzepatide is a dual incretin receptor agonist composed of 39 amino acids. It activates both GLP-1 and GIP receptors, thereby enhancing glucose-dependent insulin secretion, suppressing glucagon, delaying gastric emptying, and reducing appetite. With a half-life of approximately 5 days, it is convenient to administer via a once-weekly subcutaneous injection. Clinical trials have demonstrated that tirzepatide offers superior efficacy in terms of glycemic control and weight loss compared to selective GLP-1 receptor agonists.
Reference priceUSD 40.00
Fat loss
Tesamorelin
Tesamorelin is a synthetic 44-amino acid peptide analog that resembles growth hormone-releasing hormone (GHRH). It stimulates the release of endogenous growth hormone and increases IGF-1 levels, thereby promoting lipolysis and providing metabolic benefits. Tesamorelin has been approved by the FDA for the reduction of visceral adipose tissue in individuals with HIV-associated lipodystrophy.
Reference priceUSD 41.00